Dr. Ross Camidge, University of Colorado, discusses management of CNS progression for ALK-positive NSCLC including monitoring frequency and preferences between systemic and radiation therapy.
CNS Disease in ALK-Positive NSCLC_ Monitoring and Systemic vs. Radiation Therapy [720p]
